[The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
Matveev
B P
BP
Kariakin
O B
OB
Safiullin
K N
KN
Figurin
K M
KM
Levi
D T
DT
Vatin
O E
OE
D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000276:immunology / Q000517:prevention & control*; D011182:Postoperative Care; D012074:Remission Induction; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000517:prevention & control*
D001500:BCG Vaccine
Profilaktika retsidivov poverkhnostnogo raka mochevogo puzyria immunoterapieĭ vaktsinoĭ BTsZh.